Basal insulin and cardiovascular and other outcomes in dysglycemia

Hertzel C Gerstein; Jackie Bosch; Gilles R Dagenais; Rafael Díaz; Hyejung Jung; Aldo P Maggioni; Janice Pogue; Jeffrey Probstfield; Ambady Ramachandran; Matthew C Riddle; Lars E Rydén; Salim Yusuf; ORIGIN Trial Investigators; Thure Krarup; Hans Jørgen Duckert Perrild; Christian Tobias Torp-Pedersen

doi:10.1056/NEJMoa1203858

Basal insulin and cardiovascular and other outcomes in dysglycemia

Hertzel C Gerstein, Jackie Bosch, Gilles R Dagenais, Rafael Díaz, Hyejung Jung, Aldo P Maggioni, Janice Pogue, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle, Lars E Rydén, Salim Yusuf, ORIGIN Trial Investigators, Thure Krarup, Hans Jørgen Duckert Perrild, Christian Tobias Torp-Pedersen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

1456 Citationer (Scopus)

Abstract

The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested.

Originalsprog	Engelsk
Tidsskrift	New England Journal of Medicine
Vol/bind	367
Udgave nummer	4
Sider (fra-til)	319-28
Antal sider	10
ISSN	0028-4793
DOI	https://doi.org/10.1056/NEJMoa1203858
Status	Udgivet - 2012

Adgang til dokumentet

10.1056/NEJMoa1203858

Citationsformater

Gerstein, H. C., Bosch, J., Dagenais, G. R., Díaz, R., Jung, H., Maggioni, A. P., Pogue, J., Probstfield, J., Ramachandran, A., Riddle, M. C., Rydén, L. E., Yusuf, S., ORIGIN Trial Investigators, Krarup, T., Perrild, H. J. D., & Torp-Pedersen, C. T. (2012). Basal insulin and cardiovascular and other outcomes in dysglycemia. New England Journal of Medicine, 367(4), 319-28. https://doi.org/10.1056/NEJMoa1203858

Gerstein, HC, Bosch, J, Dagenais, GR, Díaz, R, Jung, H, Maggioni, AP, Pogue, J, Probstfield, J, Ramachandran, A, Riddle, MC, Rydén, LE, Yusuf, S, ORIGIN Trial Investigators, Krarup, T, Perrild, HJD & Torp-Pedersen, CT 2012, 'Basal insulin and cardiovascular and other outcomes in dysglycemia', New England Journal of Medicine, bind 367, nr. 4, s. 319-28. https://doi.org/10.1056/NEJMoa1203858

@article{46b6ccc5b8ea4ad9a7b8c35718ffa9ad,

title = "Basal insulin and cardiovascular and other outcomes in dysglycemia",

abstract = "The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested.",

author = "Gerstein, {Hertzel C} and Jackie Bosch and Dagenais, {Gilles R} and Rafael D{\'i}az and Hyejung Jung and Maggioni, {Aldo P} and Janice Pogue and Jeffrey Probstfield and Ambady Ramachandran and Riddle, {Matthew C} and Ryd{\'e}n, {Lars E} and Salim Yusuf and Torp-Pedersen, {Christian Tobias} and Thure Krarup and Perrild, {Hans J{\o}rgen Duckert} and Torp-Pedersen, {Christian Tobias}",

year = "2012",

doi = "10.1056/NEJMoa1203858",

language = "English",

volume = "367",

pages = "319--28",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "4",

}

TY - JOUR

T1 - Basal insulin and cardiovascular and other outcomes in dysglycemia

AU - Gerstein, Hertzel C

AU - Bosch, Jackie

AU - Dagenais, Gilles R

AU - Díaz, Rafael

AU - Jung, Hyejung

AU - Maggioni, Aldo P

AU - Pogue, Janice

AU - Probstfield, Jeffrey

AU - Ramachandran, Ambady

AU - Riddle, Matthew C

AU - Rydén, Lars E

AU - Yusuf, Salim

AU - ORIGIN Trial Investigators

AU - Krarup, Thure

AU - Perrild, Hans Jørgen Duckert

AU - Torp-Pedersen, Christian Tobias

PY - 2012

Y1 - 2012

N2 - The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested.

AB - The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested.

U2 - 10.1056/NEJMoa1203858

DO - 10.1056/NEJMoa1203858

M3 - Journal article

C2 - 22686416

SN - 0028-4793

VL - 367

SP - 319

EP - 328

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 4

ER -